Johnson & Johnson: I'm Saying Yes To This Mess

Johnson & Johnson (NYSE: JNJ ) is a one big enigma right now. And I like it. I’ve owned it since May and it has been a experience not unlike many I have had with other high quality dividend stocks. It isI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden YARP Portfolio, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income investing. I've been charting investments since the 1980s, ...